David ShaywitzOvjeren akaunt

@DShaywitz

MD,PhD;Founder, Astounding HealthTech-Advisory Services, supporting drug developers; TechTonics (bk, pcast). Not engaged on twitter/broadcast only (via )

Bay area
Vrijeme pridruživanja: listopad 2011.

Tweetovi

Blokirali ste korisnika/cu @DShaywitz

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DShaywitz

  1. Prikvačeni tweet

    “I've lost close family members to cancer that didn't yet have treatments available, the hardest part for them wasn't affording it. A lack of innovation is access problem we often overlook because it isn't as salient-but it is a far larger barrier than price.” -

    Poništi
  2. 29. sij

    Key point re: EHR cos in interoperability news lately. Their key stakeholders=leading AMCs; AMCs are the ones who buy the huge contracts. Hard to escape idea that EHR co's basically give AMC's plausible deniability around data sharing; if AMC leadership wanted it, it would happen

    Poništi
  3. 29. sij

    Must-read, describing experiences of as he tries to get own hlth records (unsuccessfully), & has his meds misrecorded- i.e. the usual. He also lambasts anti-interop of certain EHR co's. Resonates w/recent

    Poništi
  4. 27. sij

    Passionate by + ripping Epic's 11th hr opposition to interop. If only AMCs had some way to influence a co like Epic....Cynic would say Epic enables AMC docs to honestly plead for interop, yet serving AMC CFOs by forestalling it

    Poništi
  5. 27. sij

    As nicely summarizes, I'm "not as pessimistic abt tech as many emerging critics of Silicon Valley. But [I'm] listening 2what critics have 2say, & seeing ways in which today's debate can contribute to a better future in the area of healthtech"

    Poništi
  6. 27. sij

    Latest Astounding HealthTech Techlash challenges assumptions of tech's inevitability-a good thing. +Why, given choice betw Siebel's digital transformation (~panopticon FTW) & "Surveillance Capitalism," I vote for ...

    Poništi
  7. 24. sij

    (Fixed link) Latest Astounding HealthTech column : Incrementalism, Trust,& other takeaways from + track I hosted at this wk

    Poništi
  8. 24. sij

    Powerful (and 100% apolitical) essay highlighting just how deeply and fundamentally uncertain so much of medicine remains - more than rule than the exception, I suspect. cc

    Poništi
  9. 23. sij

    At yesterday, Brook Byers, like many, praised direction of towards seeking improved tech and considering approvals in light of risk and need. He also called out concerning recent NYT op-ed expressing hope approvals slow down.

    Poništi
  10. 23. sij

    In the same way gets the most consistently amazing biopharma guests for The Long Run pcast (), so impressed with health systems guests on , . Latest show GREAT!

    Poništi
  11. 23. sij

    Gr8 panel feat , (nee ) (see beautiful post ), . Intrstng how much cutting edge healthtech venture driven by historically tech funds, with new savvy HC domain expertise

    Poništi
  12. 22. sij

    Relevant interoperability slides at from cc

    Poništi
  13. 22. sij

    Great 2b at Silicon Valley where I’m privileged to both MC AI+Data Science track, & moderate afternoon panel on data viz & mining feat + leaders from . Great 2c

    Poništi
  14. 22. sij

    Yet another interesting episode, this on innov and pharma, smart comments as usual from among others.

    Poništi
  15. 22. sij

    2/2 ... that specific distrust of GOOG is because their product=ur data so it feels especially parasitic. What's needed in space is theoretical benefit of data aggregation to find expression in tactile application that offers unambiguous benefit to patients. cc

    Poništi
  16. 22. sij

    1/2 Outstanding article by abt challenges tech co's, esp Google, face in health arena. Feat smart quotes from & among others. I thought entrepreneur nailed it by noting...

    Poništi
  17. 21. sij

    Probably representative-operational improvements touted as easy win of digital transformation, so it’s amusing to have spent literally hours-still unsuccessfully-trying to get myself registered (in response to invite) as vendor in a big pharma system -> . Dreadful.

    Poništi
  18. 20. sij

    Love this new , featuring Matthew DeSilva of . Poignant discussion of Matt's journey from a quant working for Peter Thiel's Clarium Capital to head of a personalized medicine lab and company. cc

    Poništi
  19. 17. sij

    This is a how a digital transformation protagonist envisions the tech revolution improving our healthcare future... seems important to decide if such comprehensive continuous surveillance is worth anticipated benefits—assume such benefits even materialize

    Poništi
  20. 17. sij

    As every business is pushed to urgently undertake a “digital transformation,” I thought it might be helpful to understand more about the ideology behind this mandate, as well as to examine anticipated implications for healthcare and for businesses.

    Poništi
  21. 17. sij

    "Digital Transformation" is ideology of the moment in business. What does this actually mean? In my latest Astounding HealthTech column , I review basic tenets lays out, & discuss implications for biopharma/HC, and for org change

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·